Product Description
Companion solutions are digital tools, primarily mobile apps, software platforms, or sensor-integrated systems designed to support the use of specific pharmaceutical drugs or medical devices. These solutions provide a range of patient support services such as symptom tracking, medication reminders, educational content, adherence monitoring, telehealth integration, and, in some cases, drug or device ordering. Unlike general health apps, companion solutions are closely tied to a particular therapy or product.
This new report by Research2Guidance provides pharmaceutical executives and digital health leaders with a comprehensive overview of the emerging companion app market and its growing strategic importance. As the pharmaceutical industry increasingly turns to digital tools to enhance drug performance and patient outcomes, companion solutions are becoming a key area of investment.
The report outlines what companion apps are, the range of services they offer across the patient journey, and the tangible commercial and clinical benefits they can deliver, including improved adherence, retention, and earlier patient identification.
Pharma managers looking to explore or expand their digital health strategies will find actionable insights into which drug types are best suited for companion apps. Using a structured classification and a set of best-fit criteria, the report helps decision-makers evaluate their existing portfolios and pipeline drugs to identify where a companion solution could deliver the highest impact.
The report also provides a market outlook, including a 2029 forecast on
- Drugs supported by companion apps,
- Available companion apps,
- Addressable drug market size, divided into on-patent drugs, generic drugs, and over-the-counter drugs
- Addressable target patient group sizes
- Companion app user development
- Companion app induced incremental total drug revenue
- Average incremental drug sales value for a companion app supported drug
- Forecast per region: North America, Europe, and Rest of World
The report provides a detailed overview and categorization of companion apps, organizing them by key features, stages of the patient journey they support, and the business objectives they are designed to achieve.
In short, The Rise of Companion Apps provides pharma managers with the knowledge and frameworks needed to assess the full potential of digital companion solutions and to make informed decisions about where and how to invest in this growing field.
Research2Guidance has been monitoring the digital health market since 2010. This report will act as a baseline for future analyses of the digital health business organizations in the market.
Questions about the content of the report, the methodology, or how to order, please contact us at: [email protected]